This led to focus on the possible anti-tumor effect of TU-100 to cancel the interaction between HSCs and tumor cells, and present studies have shown that TU-100 has inhibited HSC activation promoted by cancer cells, and suppressed the secretion of IL-6 in HSCs. Here, IL6 is linked to neoplasm.